Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.

Robert H I AndtbackaBrendan CurtiGregory A DanielsSigrun HallmeyerEric D Whitman Jose LutzkyLynn E SpitlerKarl ZhouPraveen K BommareddyMark GroseMeihua WangCai Wu Howard L Kaufman

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)

V937 was well tolerated and warrants further investigation for treatment of patients with unresectable melanoma. Studies of combination approaches with V937 and immune checkpoint inhibitors are ongoing.

Keyphrases

locally advanced
liver metastases
skin cancer
squamous cell carcinoma
basal cell carcinoma
replacement therapy